Clinical Trial Update: Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis [NA]

View source ↗

Summary

A clinical trial update shows a study adding evolocumab to standard lipid-lowering therapy for hypertriglyceridemia-induced acute pancreatitis is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia-induced Acute Pancreatitis

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Hypertriglyceridemia Induced Acute Pancreatitis | NA | Status: RECRUITING